American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Kris
    Kris
  7. Hudis
    Hudis
  8. Morris
    Morris
  9. Rosenberg
    Rosenberg
  10. Robson
    Robson

Groups

  1. Department of Medicine (6400)
  2. Solid Tumor Oncology Division (5538)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)
  7. GSK Faculty (1389)
  8. Population Sciences Research Program (1379)
  9. Gastrointestinal Oncology Service (1354)
  10. Hematologic Malignancies, Division of (1281)
Search Within
Formats
  1. Meeting Abstract (6334)
  2. Journal Article (2582)
  3. Editorial (76)
  4. Review (68)
  5. Guidelines (55)
  6. Correspondence (49)
  7. Miscellaneous (4)
  8. Conference Paper (3)
Groups
  1. Department of Medicine (6400)
  2. Solid Tumor Oncology Division (5538)
  3. Survivorship Research (1997)
  4. Genitourinary Oncology Service (1768)
  5. Surgery (1637)
  6. Epidemiology and Biostatistics (1495)

More Groups

People
  1. Robert Motzer (451)
  2. Howard Scher (334)
  3. Eileen O'Reilly (306)
  4. Leonard Saltz (283)
  5. Dean Bajorin (280)
  6. Mark Kris (253)

More People

Years
  1. 2025 (279)
  2. 2024 (554)
  3. 2023 (580)
  4. 2022 (554)
  5. 2021 (504)
  6. 2020 (539)

More Years

Publications
  1. Journal of Clinical Oncology (8697)
  2. JCO Precision Oncology (171)
  3. Journal of Oncology Practice (124)
  4. American Society of Clinical Oncology Educational Book (112)
  5. JCO Clinical Cancer Informatics (53)
  6. JCO Oncology Practice (8)

More Publications

Results (9171)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical targeted next-generation panel sequencing reveals MYC amplification is a poor prognostic factor in osteosarcoma
    Journal Article

    Marinoff, A. E.; Spurr, L. F.; Fong, C.; Li, Y. Y.; Forrest, S. J.; Ward, A.; Doan, D.; Corson, L.; Mauguen, A.; Pinto, N.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Benchmarking outcomes for molecularly characterized synchronous oligometastatic non-small-cell lung cancer reveals EGFR mutations to be associated with longer overall survival
    Journal Article

    De, B.; Farooqi, A. S.; Mitchell, K. G.; Ludmir, E. B.; Lewis, J.; Rinsurongkawong, W.; Rinsurongkawong, V.; Lee, J. J.; Swisher, S. G.; Gibbons, D. L.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Orthogonal testing unravels a novel ROS1 Oncogenic Fusion Variant (ROS1-GPM6A): A practical approach to molecular testing for actionable fusion variants
    Journal Article

    Narvel, H. G.; Kim, S. Y.; Shokrekhuda, A. M.; Cohen, P. R.; Ramesh, K. H.; Solomon, S. R.; Paik, P. K.; Halmos, B.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Precision management of a patient with dihydropyrimidine dehydrogenase deficiency and liver-predominant metastatic rectal cancer using hepatic arterial floxuridine
    Journal Article

    Lumish, M.; Thackray, J.; Do, R. K. G.; Caudle, K. E.; Amstutz, U.; Schwab, M.; Diasio, R. B.; Jarnagin, W. R.; Cercek, A.
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Pathway alterations in stage II/III primary melanoma
    Journal Article

    Kostrzewa, C. E.; Luo, L.; Arora, A.; Seshan, V. E.; Ernstoff, M. S.; Edmiston, S. N.; Conway, K.; Gorlov, I.; Busam, K.; Orlow, I.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • HERTHENA-Lung01, a phase II trial of patritumab deruxtecan (HER3-DXd) in epidermal growth factor receptor–mutated non–small-cell lung cancer after epidermal growth factor receptor tyrosine kinase inhibitor therapy and platinum-based chemotherapy
    Journal Article

    Yu, H. A.; Goto, Y.; Hayashi, H.; Felip, E.; Yang, J. C. H.; Reck, M.; Yoh, K.; Lee, S. H.; Paz-Ares, L.; Besse, B.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Systemic therapy for small-cell lung cancer: ASCO-Ontario Health (Cancer Care Ontario) guideline
    Guidelines

    Khurshid, H.; Ismaila, N.; Bian, J.; Dabney, R.; Das, M.; Ellis, P.; Feldman, J.; Hann, C.; Kulkarni, S.; Laskin, J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Flashback Foreword: Gemcitabine for advanced pancreatic cancer
    Editorial

    O'Reilly, E. M.; Ko, A. H.; Friedberg, J. W.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer: Results from the innovaTV 205/GOG-3024/ENGOT-cx8 study
    Journal Article

    Vergote, I.; Van Nieuwenhuysen, E.; O'Cearbhaill, R. E.; Westermann, A.; Lorusso, D.; Ghamande, S.; Collins, D. C.; Banerjee, S.; Mathews, C. A.; Gennigens, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Health-related quality of life with nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric/gastroesophageal junction cancer or esophageal adenocarcinoma from CheckMate 649
    Journal Article

    Moehler, M.; Xiao, H.; Blum, S. I.; Elimova, E.; Cella, D.; Shitara, K.; Ajani, J. A.; Janjigian, Y. Y.; Garrido, M.; Shen, L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save